AB Science Stock Jumps 4.15% at Midday, Reaching a 3-Month High
AB Science stock shows strong progress this Tuesday at midday, recording a gain of 4.15% at 1.306 euros. This advance occurs in a context of a significant rebound in European markets, with the CAC 40 up 2.16% and the DAX up 2.22% during the session. The bullish movement allows the French biotech to move away from its technical support threshold after several weeks of consolidation.
Technical Indicators and Recent Performance
This Tuesday, AB Science stock is trading above its 200-day moving average, located at 1.29 euros, after repeatedly testing its support at 1.24 euros — a level that also corresponds to the lower Bollinger Band. The breach of this technical floor had been contained in recent sessions, and the price is now gaining height. The RSI is at 45, a still neutral zone that does not indicate overbuying, leaving room for progression before reaching tension levels. However, the stock remains below its 50-day moving average (1.37 euros), which now becomes the next milestone to watch. Beyond this, the technical resistance is at 1.42 euros. Over three months, the performance remains positive at 10.87%, contrasting with a decline of 5.91% over a year. The monthly volatility, measured at 10.35, remains contained for a stock in this segment, while a beta of 0.25 reflects a limited correlation with the overall market.
Market Context and Regional Dynamics
Today's session is characterized by a generalized rebound movement in European stock markets. The CAC 40 is up 2.16% during the session at 8,086.64 points, while the SBF 120 is up 2.19%. In London, the FTSE 100 gains 1.67%. In Asia, the momentum was also favorable: the Nikkei 225 closed up 2.88% and the Hang Seng ended with a gain of 2.17%. This renewed appetite for risk assets comes as the VIX, the implied volatility indicator of the S&P 500, was at 29.49 on Friday, up sharply by 24.17% from the previous day, reflecting a high level of tension in the American markets. This discrepancy between nervousness in America and recovery in Europe illustrates distinct regional dynamics. For AB Science, whose low beta generally limits exposure to overall movements, today's rise significantly outperforms that of the Paris market. The stock thus returns to a price of 1.306 euros, a level not seen since the end of February. The next resistance at 1.42 euros represents a potential progression of about 8.7% from the current price.
